000 01465 a2200421 4500
005 20250518080241.0
264 0 _c20200409
008 202004s 0 0 eng d
022 _a1546-1696
024 7 _a10.1038/s41587-019-0329-2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMacKay, Matthew
245 0 0 _aThe therapeutic landscape for cells engineered with chimeric antigen receptors.
_h[electronic resource]
260 _bNature biotechnology
_c02 2020
300 _a233-244 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aCell Engineering
_xmethods
650 0 4 _aCell- and Tissue-Based Therapy
650 0 4 _aClinical Trials as Topic
650 0 4 _aGene Expression Regulation, Neoplastic
650 0 4 _aHumans
650 0 4 _aNeoplasms
_xgenetics
650 0 4 _aReceptors, Chimeric Antigen
_xmetabolism
700 1 _aAfshinnekoo, Ebrahim
700 1 _aRub, Jonathan
700 1 _aHassan, Ciaran
700 1 _aKhunte, Mihir
700 1 _aBaskaran, Nithyashri
700 1 _aOwens, Bryan
700 1 _aLiu, Lauren
700 1 _aRoboz, Gail J
700 1 _aGuzman, Monica L
700 1 _aMelnick, Ari M
700 1 _aWu, Shixiu
700 1 _aMason, Christopher E
773 0 _tNature biotechnology
_gvol. 38
_gno. 2
_gp. 233-244
856 4 0 _uhttps://doi.org/10.1038/s41587-019-0329-2
_zAvailable from publisher's website
999 _c30489290
_d30489290